| 在卫生领域开发和使用生物标记物的政策性问题（Ⅱ） |
| |
| 引用本文： | Rachael Ritchie,Marie-Ange Baucher. 在卫生领域开发和使用生物标记物的政策性问题（Ⅱ）[J]. 科学观察, 2013, 0(6): 1-17 |
| |
| 作者姓名： | Rachael Ritchie Marie-Ange Baucher |
| |
| 作者单位： | 经济合作与发展组织 |
| |
| 摘 要： | 该报告描述了发展中的生物标记物所处的科学、产业、监管和医疗保健管理系统背景，指出了可能阻碍生物标记物研究、发现、发展、商业化及最终临床应用的一些障碍，聚焦了医疗保健中基于生物标记物的诊断方法和医学检验的应用，探索了生物标记物在改良药物开发中的应用。
|
| 关 键 词： | 生物标记物 政策 医疗 保健 经合组织 |
Policy Issues for the Development and Use of Biomarkers in Health |
| |
| Affiliation: | Rachael Ritchie, Marie-Ange Baucher Organisation for Economic Co-operation and Development (OECD) |
| |
| Abstract: | This report describes the scientific, industrial, regulatory, and health care management system context in which biomarkers are being developed. It identifies some of the barriers which may impede biomarker research, discovery, development, commercialisation and, ultimately, uptake in clinics. It also focuses on the use of biomarkers in the health care system, as diagnostics and in medical tests, and explores the use of biomarkers for the development of improved medicines. |
| |
| Keywords: | biomarkers policy health care system OECD |
| 本文献已被 维普 等数据库收录！ |
|
